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Food allergies are increasing in prevalence at a higher rate
than can be explained by genetic factors, suggesting a
role for as yet unidentified environmental factors. In this
review, we summarize the state of knowledge about the
healthy immune response to antigens in the diet and
the basis of immune deviation that results in immunoglob-
ulin E (IgE) sensitization and allergic reactivity to foods.
The intestinal epithelium forms the interface between the
external environment and the mucosal immune system,
and emerging data suggest that the interaction between
intestinal epithelial cells and mucosal dendritic cells is
of particular importance in determining the outcome of
immune responses to dietary antigens. Exposure to food
allergens through non-oral routes, in particular through
the skin, is increasingly recognized as a potentially impor-
tant factor in the increasing rate of food allergy. There are
many open questions on the role of environmental factors,
such as dietary factors andmicrobiota, in the development
of food allergy, but data suggest that both have an impor-
tant modulatory effect on the mucosal immune system.
Finally, we discuss recent developments in our under-
standing of immune mechanisms of clinical manifesta-
tions of food allergy. New experimental tools, particularly
in the field of genomics and the microbiome, are likely to
shed light on factors responsible for the growing clinical
problem of food allergy.
Introduction
Food allergy is an immune-mediated adverse reaction to
food and is a growing clinical problem. It is not currently
understood why some individuals develop allergic sensitiza-
tion to allergenic foods while the majority of individuals
are immunologically tolerant, but evidence suggests that
environmental factors are important. In this review, we will
outline what is known about the healthy immune response
to foods and what is currently understood about the immune
mechanisms leading to allergic sensitization. Although the
field is young and there is a lack of a comprehensive under-
standing of risk factors associated with development of food
allergy, we will review emerging literature on the role of diet,
gut microbiota, and exposure to food allergens through
non-oral routes in the development of food allergy. Finally,
immune mechanisms responsible for the different clinical
manifestations of food allergy will be discussed.
Food Allergy
Food allergy is defined as ‘‘an adverse health effect arising
from a specific immune response that occurs reproducibly
on exposure to a given food’’ [1] and encompasses a range
of disorders from IgE-mediated anaphylaxis to delayed
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(H.A.S.)respiratory tract or skin. For the purpose of this review, we
will focus primarily on the food allergies mediated by
immunoglobulin E (IgE); readers are referred to recent
reviews for information on cell-mediated disorders, including
food-protein-induced enterocolitis syndrome [2] or eosino-
philic esophagitis [3]. IgE-mediated reactions typically occur
within two hours of ingestion of the food, and involve the
skin, gastrointestinal tract, respiratory tract and, less fre-
quently, the cardiovascular system. In the most severe
case of anaphylaxis, multiple organ systems are involved
and can include cardiovascular collapse.
Although true prevalence rates of IgE-mediated food
allergy have been difficult to accurately estimate, as re-
viewed by Sicherer [4], a systematic review of the literature
concluded that food allergy affects greater than 2% and
less than 10% of the general population [5]. A population-
based study from Australia demonstrated a greater than
10% rate of IgE-mediated food allergy in response to oral
challenge in a cohort of infants at one year of age [6]. The
majority of children allergic to milk or egg will outgrow their
food allergies, but in contrast peanut, tree nut, fish and shell-
fish allergies are most commonly lifelong. The prevalence of
food allergy is increasing [7]. In repeated studies of the prev-
alence of peanut allergy in a US population based on random
telephone survey performed in 1997, 2002, and 2008, it was
found that the prevalence of peanut allergy increased from
0.4% to 0.8% to 1.4%over the three time points [8–10]. Rates
of peanut allergy over 1% are consistent with reports from
Canada [11], the UK [12], and Australia [13], including studies
that employed physician evaluation and food challenges.
Although there is a significant genetic component to food
allergy, the rapid rise in the prevalence of food allergy sug-
gests an important contribution from environmental factors.
We will review emerging research on the role of factors that
may contribute to the rising rate of allergic sensitization to
foods through modulatory effects on the mucosal immune
system.
Introduction to the Mucosal Immune System
The gastrointestinal tract is the largest reservoir of immune
cells in the body, and the function of the mucosal immune
system is to protect the large surface area of the gastroin-
testinal tract from invading pathogens and to keep the
commensal microbiota compartmentalized. The mucosal
immune system is divided from the gut lumen by a single
layer of columnar epithelial cells, which secrete a number
of factors that contribute to barrier function, including
mucins, antimicrobial peptides, and trefoil factors. The
epithelial cells also transport antibodies, particularly IgA,
into the intestinal lumen where these antibodies can
contribute to barrier function by excluding the uptake of
antigens or microbes. (Readers are referred elsewhere [14]
for a comprehensive review of regulation of the epithelial
barrier function.) Below the epithelium lies the mucosa,
which is densely populated by resident immune cells, in-
cludingCD4+ andCD8+ T effector and regulatory T cells, anti-
body-secreting B cells, and mononuclear phagocytes
(macrophages and dendritic cells): see Box 1 for a glossary
of immunological terms used in this review. Eosinophils are
also resident cells in the normal intestinal mucosa. These
scattered immune cells make up the effector sites of the
Box 1
Glossary of immunology terminology.
Innate immunity An immediate response to infection or damage that is mediated through recognition of conserved patterns.
Recognition occurs via pattern recognition receptors, such as Toll-like receptors, NOD-like receptor proteins,
and endocytic/phagocytic pattern recognition receptors, such as mannose receptor or DC-SIGN. Effector
mechanisms of innate immunity are diverse and include the release of anti-microbial peptides, killing through
release of cytotoxic molecules, phagocytosis and intracellular killing of microbes, complement activation, release
of innate cytokines (IL-1b, IL-6, and tumor necrosis factor-a, TNF-a) and release of acute-phase proteins from the
liver that assist in pathogen clearance.
Adaptive immunity Adaptive immunity is mediated by T and B lymphocytes, which recognize specific antigens through their T-cell
receptor (TCR) andB-cell receptor (BCR), respectively. The adaptive immune responses are slower than the innate
immune response, but have the property of memory, such that subsequent responses to the same antigen are
more rapid. T cells can be divided into cytotoxic (CD8+) and helper (CD4+) T cells. CD4+ T cells can be further
subdivided based on the cytokines they secrete. In general, Th1 cells express the transcription factor T-bet,
secrete IFN-g and assist in clearing intracellular pathogens by activating macrophages; Th2 cells express the
transcription factor GATA-3, secrete IL-4, IL-5 and IL-13, and provide help to B cells for antibody production and
promote allergic responses; Th17 cells express the transcription factor RORgt, secrete IL-17, and play an
important role in microbial clearance and a destructive role in autoimmunity. Regulatory T cells suppress these
effector T-cell responses, and regulatory T cells come in a variety of different phenotypes. B cells contribute to
adaptive immunity by secreting antibodies that can neutralize pathogens, activate complement, and activate
antibody-dependent cell-mediated cytotoxicity pathways. Antibodies of the IgE isotype trigger allergic reactions.
Dendritic cells Dendritic cells are resident cells of tissues, acquire antigen and process it for presentation on major
histomcompatibility complex (MHC) molecules, and migrate to lymph nodes for presentation of antigen to
T lymphocytes. Dendritic cells are the most potent antigen-presenting cells capable of priming naı¨ve T cells.
Cytokines A cytokine is a small protein made by a cell that affects the behavior of other cells. Cytokines can be grouped into
categories based on their function. Innate cytokines (IL-1b, IL-6, TNFa) are released by a variety of stromal cells
and macrophages early in infection and play a role in pathogen clearance. Th1, Th2, and Th17 cytokines are
outlined under ‘adaptive immunity’. Cytokines released from innate cells and antigen-presenting cells can act
on naı¨ve T cells to influence their developmental fate. IL-12 promotes the development of Th1 cells, IL-4 promotes
the development of Th2 cells, and IL-6 and TGF-b promote the development of Th17 cells.
Chemokines and homing
molecules
Chemokines are chemotactic cytokines that act on G-protein-coupled surface receptors. Cells respond to
chemokines through migration along a chemokine gradient. Tissue-specific homing is mediated through
chemokine–chemokine receptor interaction as well as integrin–ligand interactions. Gut homing is mediated by
the chemokine receptor CCR9 and its ligand CCL25 (expressed in the small intestine), as well as the integrin a4b7
and its ligand MAdCAM, which is also differentially expressed in the intestine. Skin homing is mediated by the
chemokine receptors CCR4 and CCR10 in response to the ligands CCL17, CCL22, and CCL27, which are
expressed in the skin. In addition, the integrin cutaneous lymphocyte antigen (CLA) on lymphocytes binds
to E-selectin.
Regulatory T cells Regulatory T cells can be CD4+ or CD8+, although the most commonly recognized regulatory T cell is the CD4+
Foxp3+ form. Foxp3+ regulatory T cells can be generated in the thymus (natural regulatory T cells ) or generated
from naı¨ve T cells in the periphery (induced regulatory T cells). Regulatory T cells use a variety of suppressive
mechanisms, including cytokines (TGF-b and IL-10), cell–cell interaction (for example, involving the surface
molecule CTLA-4), and can also suppress by cytolytic activity.
Co-stimulatory molecules Thesemolecules are expressed on the surface of antigen-presenting cells and provide additional signals to shape
the nature of the T-cell response. Co-stimulatory molecules can provide an activating signal, such as when B7.1
and B7.2 bind to CD28 on the T-cell surface. Alternatively, inhibitory signals can be provided by co-stimulatory
molecules, such as when B7.1 and B7.2 bind to CTLA-4 instead of CD28 and provide an ‘off’ switch to T-cell
activation. Expression of other co-stimulatory molecules, such as OX40L, or Notch ligands on antigen-presenting
cells can influence the differentiation of naı¨ve T cells through binding to surface receptors on T cells.
Innate lymphoid cells Innate lymphoid cells are innate cells that share characteristics with CD4+ T cells, but do not recognize specific
antigen within the context of MHCmolecules. These cells represent a distinct category of different innate immune
cells, but features in common include localization at mucosal sites and production of cytokines that play a role in
mucosal homeostasis and regulation of the intestinal microbiota as well as in pathogenesis of intestinal and
allergic disease.
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clear pathogenic challenges from the environment. Inductive
sites — locations where antigen-specific cellular and hu-
moral immune responses are first generated — include
Peyer’s patches and isolated lymphoid follicles that sit
directly within the gut mucosa, and the mesenteric lymph
nodes that drain the gastrointestinal tract, including Peyer’s
patches, via the lymph. A specialized subset of epithelial
cells termed M cells overlies the Peyer’s patches and con-
tributes to the selective uptake of particulate antigens at
this site. In contrast, soluble antigens are primarily takenup across the epithelium lining the villi and are carried into
the mesenteric lymph nodes.
A challenge faced by the mucosal immune system is to
discriminate between harmful pathogens and harmless or
beneficial commensal organisms. The lack of reactivity to
the commensal flora is in part achieved by a specialized
regulatory milieu that may also shape the immune response
to antigens derived from the diet. Antigen-presenting cells
andmacrophages of the intestinal mucosa are hypo-respon-
sive to many microbial ligands [15] and secrete high levels of
immunoregulatory cytokines, such as interleukin-10 (IL-10)
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sion of inappropriate immune reactivity to microbes or
food antigens may be quite different. For example, targeted
deletion of a number of immune regulatory components
(such as IL-10) will result in a microbiota-dependent colitis
[17], but spontaneous allergy to dietary components or
allergic inflammation is rarely described in these models.
Normal Response to Foods: Mechanisms of Oral
Tolerance
As was first described by Osborne and Wells in 1911 [18],
antigens that are present in the diet induce a systemic
non-responsiveness that has been termed ‘oral tolerance’.
Antigens present in the diet could not elicit an immune
response after parenteral immunization. This has also been
demonstrated in human subjects after feeding and immuni-
zation with the neoantigen keyhole limpet hemocyanin
[19,20]. The finding that this was an active regulatory
response was demonstrated by transferring tolerance to
naı¨ve mice through the transfer of T cells. However, T-cell
anergy and deletion —mechanisms of tolerance that cannot
be transferred to naı¨ve mice — have also been shown to
contribute to the development of oral tolerance in some
experimental systems.
T cells with a suppressive phenotype were described in
the Peyer’s patches and later in the spleen after antigen
feeding [21–23], but several studies have shown that the
Peyer’s patches are dispensable for the development of
tolerance [24,25]. In contrast, the mesenteric lymph nodes
have been shown to be required for the development of toler-
ance. Surgical or immunological ablation of the mesenteric
lymph nodes prevents the development of oral tolerance
[26,27]. The migration of immune cells to the intestine and
from the intestine to the draining lymph nodes is controlled
by the regulated expression of chemotactic cytokines
(chemokines) and chemokine receptors. The chemokine
receptor CCR7, which is necessary for the migration of den-
dritic cells from the lamina propria to the mesenteric lymph
nodes where CCR7 ligands are expressed, is also necessary
for the development of oral tolerance [27]. Global expansion
of dendritic cells with the growth factor Flt3L decreases the
amount of antigen required to induce oral tolerance [28], and
tolerance can be transferred to naı¨ve animals by transfer of
dendritic cells derived from the intestinal lamina propria
[29]. There have been no reports about the effect of dendritic
cell ablation on the development of oral tolerance.
Role of Gastrointestinal Antigen-Presenting Cells
The biology of the mononuclear phagocyte system in the
gastrointestinal tract is currently the focus of a great deal
of research and some debate. The initial description that
dendritic cells could extend dendrites across the intestinal
epithelium [30,31] and capture bacteria from the intestinal
lumen generated much interest in this cell subset. These
CD11c+ dendritic cells express the chemokine receptor
CX3CR1, which is necessary for the extension of the trans-
epithelial dendrites into the lumen [32]. These cells are
derived from monocytes in an M-CSF receptor-dependent
manner, express the surface marker F4/80, do not constitu-
tively express CCR7, and do not migrate in lymph [33,34].
By transcriptional analysis they are more closely related to
tissue macrophages than tissue dendritic cells [35]. In
contrast, CX3CR1
2 CD103+ dendritic cells in the lamina pro-
pria constitutively express CCR7 and migrate to themesenteric lymph nodes. These cells arise from common
dendritic cell progenitors and pre-dendritic cells in a GM-
CSF receptor-dependent manner [33,34]. Although CD103+
dendritic cells do not extend dendrites between epithelial
cells, they sample antigens from goblet cells, which function
as a conduit between the lumen and the mucosa [36]. In
addition, they may sample antigens that are transported
across the intestinal epithelium by a number of different
mechanisms, including transcellular or paracellular path-
ways or sampling by M cells. CD103+ dendritic cells isolated
from the mesenteric lymph nodes of mice and humans pref-
erentially induce the generation of gut-homing CD4+ Foxp3+
regulatory T cells from naı¨ve T cells. Although CD103 is a
marker of these dendritic cells, it is not itself involved in
the generation of gut-homing regulatory T cells. These
CD103+ dendritic cells express high levels of the enzyme
retinal dehydrogenase 2 (RALDH2), which converts retinal
to retinoic acid. Both gut homing activity (via expression
of chemokine receptors and integrins) as well as the re-
gulatory activity of the responder T cells are dependent on
retinoic acid derived from CD103+ dendritic cells. An
important source of the precursor for retinal comes from
the diet in the form of vitamin A (readers are referred to a
recent review [37] on the role of retinoic acid in mucosal
immunity).
In addition to generating regulatory T cells through expres-
sion of RALDH2, CD103+ dendritic cells also use a variety of
other mechanisms that promote the development of regula-
tory T cells, involving other enzymes, such as indoleamine
2,3-dioxygenase, and secretion of immunosuppressive cyto-
kines, such as transforming growth factor b (TGF- b), which
promote the development of regulatory T cells from naı¨ve
T cells [38–40]. This subset of intestinal dendritic cells also
promotes the development of IgA-secreting, gut-homing
plasma cells through retinoic acid and IL-6 [41,42]. Although
CD103+ dendritic cells are migratory, whereas CX3CR1
macrophages are not, a population of CX3CR1
intermediate
F4/802 CD1032 CD11c+ dendritic cells has been shown to
be present in intestine-draining lymph collected under
steady-state conditions, and these cells are preferentially
able to induce the secretion of cytokines interferon-g
(IFN-g) and IL-17 from naı¨ve T cells [43]. IFN-g and IL-17
are cytokines produced by effector T cells and are involved
in protection against pathogens. Their role in normal gut
homeostasis or response to dietary antigens is poorly
understood, but it is possible that different subsets of intes-
tinal dendritic cells have different roles. For example, the
CD103+ dendritic cells may be regulatory under steady-state
conditions, while CD1032 dendritic cells prime the immune
system to respond to pathogens. The balance of these den-
dritic cells may play an important role in maintaining gut
homeostasis. Furthermore, although CX3CR1
high intestinal
macrophages do not migrate to initiate T-cell responses,
they express high levels of IL-10 in response to interaction
with the intestinal microbiota and are thought to be impor-
tant for the expansion of regulatory T cells that have homed
back to the gut after initial priming in the mesenteric lymph
nodes [44]. In addition to cues provided by the dendritic cells
themselves to naı¨ve T cells, stromal cells of the mesenteric
lymph nodes express high levels of retinoic acid-generating
enzymes and are important for the generation of a gut-
homing phenotype in lymphocytes [45]. These stromal cells
may also contribute to the immunoregulatory function of
the gastrointestinal tissue.
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Figure 1. Mechanism of oral tolerance
induction.
Antigens are captured in the lamina propria
and Peyer’s patch and carried to the mesen-
teric lymph node (MLN) by CD103+ den-
dritic cells, which induce gut-homing (a4b7+)
induced regulatory T cells (iTregs) by a mech-
anism dependent on TGF-b, retinoic acid
(RA) and indoleamine-2,3-dioxygenase (IDO).
Dendritic cells induce gut-homing IgA-
secreting plasma cells also through RA-
dependent mechanisms. Gut-homing iTregs
are expanded in the lamina propria by IL-10-
expressing CX3CR1
+ macrophages. These
iTregs can then suppress systemic immune
responses, including allergic sensitization, in
an antigen-specific manner. The immune
mechanism of Th3 induction has not been es-
tablished as for iTregs, but Th3 cells induced
by feeding also suppress systemic immune
responses.
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As mentioned previously, oral tolerance can be transferred
to a naı¨ve mouse through the transfer of T cells. This was
initially shown using either CD4+ or CD8+ T cells. CD8+
T cells can mediate tolerance, as shown by the induction of
tolerance by feeding mice the CD8 peptide SIINFEKL, but
are not necessary for the development of oral tolerance
and do not provide tolerance against allergic inflammation
driven by CD4+ T helper 2 (Th2) cells [46]. Feeding of antigen
to either mice or humans induces a regulatory CD4+ T cell
termed the Th3 cell, characterized by surface expression of
latency associated peptide (LAP), a propeptide non-cova-
lently associated with TGF-b that keeps the complex in an
inactive form [47,48]. These cells do not express CD25 or
Foxp3, and their mechanism of suppression is dependent
on TGF-b. Th3 cells are induced by antigen feeding, and their
transfer provides protection against experimental autoim-
munity. Administration of antigen by the oral route also
induces a population of CD4+ Foxp3+ CD25+ regulatory
T cells, termed induced regulatory T cells, from Foxp32 pre-
cursors [49]. Th3 cells can also promote the development of
induced regulatory T cells through their secretion of TGF-b
[50]. Foxp3+ induced regulatory T cells are required for oral
tolerance, as shown by studies in which they are specifically
depleted [44,51].
Although it has been clearly demonstrated that the default
immune response to an experimentally fed antigen is one of
tolerancemediated by regulatory T cells, it is not understood
whether the lack of clinical reactivity to normal dietary anti-
gens is an active regulatory response mediated by these
T cells. In mice and humans, a lack of Foxp3+ T cells leads
to enteropathy, eczema, and elevated IgE. Severe food
allergy can also occur as one manifestation of Foxp3 muta-
tions [52]. Mice having a more selective defect in induced
Foxp3+ regulatory T cells, with normal levels of thymically
derived ‘natural’ regulatory T cells, exhibit a Th2-skewed
mucosal inflammation and the generation of an antibody
response (of undetermined isotype) to antigens in the chow[53]. These data show that regulatory
T cells may have a role in the con-
stitutive suppression of responses to
mucosally derived antigens. Childrenwho have outgrown their milk allergy have an increased fre-
quency of circulating CD4+ CD25+ regulatory T cells after an
oral milk challenge and reduced proliferation of milk-specific
T cells; depletion of CD4+ CD25+ regulatory T cells restores
the in vitro proliferative response in milk-tolerant subjects
[54]. These data suggest that regulatory T cells may be
involved in the development of clinical tolerance to food
allergens. The presence of food-antigen-specific regulatory
T cells has not yet been demonstrated in healthy human
subjects. Figure 1 summarizes known mechanisms of toler-
ance to dietary antigens, and readers are referred to a recent
article [55] for a comprehensive review of the mechanisms of
oral tolerance.
Factors Promoting Sensitization to Foods
Experimental Adjuvants
Mice, like most humans, do not normally develop allergic
sensitization to potent food allergens, such as peanut. In
the absence of an adjuvant, the default response is oral toler-
ance. The two adjuvants that have been used most widely to
induce hypersensitivity to food are bacterial toxins: cholera
toxin (CT) and staphylococcal enterotoxin B (SEB). When
these are co-administered orally with a variety of food anti-
gens, they induce an antigen-specific Th2 response and
antigen-specific IgE production [56,57]. When mice are re-
challenged with the food antigen in the absence of adjuvant,
sensitized mice will undergo systemic anaphylaxis that can
be measured by a drop in body temperature and is associ-
ated with other symptoms affecting the skin and respiratory
tract. By examining how these adjuvants alter the mucosal
immune system, we hope to gain a better understanding of
immune pathways that can lead to allergic sensitization.
Oral administration of CT leads to a depletion of dendritic
cells from the lamina propria andmigration to themesenteric
lymph nodes [58,59]. Dendritic cells from CT-fed mice have
an enhanced capacity to induce Th2 responses from naı¨ve
T cells, as well as enhanced production of IFN-g and IL-17,
which are not pro-allergic but instead are important in host
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regulate the surface co-stimulatory molecules OX40L and
Jagged2, and neutralization of OX40L effectively suppresses
the Th2 response while having no effect on the IFN-g or IL-17
response [59]. Therefore, generation of the Th2 response by
the adjuvant CT was dependent on surface expression of
OX40L by the gastrointestinal dendritic cells. The central
role of OX40L in the induction of allergic sensitization to pea-
nut was then confirmed and extended by Chu et al. [60], who
found that repeated feeding of peanut plus CT led to upregu-
lation of OX40L on mesenteric lymph node dendritic cells,
and that neutralization of OX40L during sensitization sup-
pressed the generation of peanut-specific IgE and clinical
signs of anaphylaxis upon allergen challenge. Furthermore,
they found that the induction of OX40L on gut dendritic cells
was downstream of the upregulation of the cytokine IL-33 by
the intestinal epithelium, but was independent of thymic
stromal lymphopoietin (TSLP) or IL-25: IL-33, IL-25, and
TSLP are epithelial-derived cytokines that have been shown
to play an important role in the induction of Th2 immunity at
mucosal surfaces [61]. CT is unlikely to play a role in human
food allergy, but these data suggest that comparable factors
that can promote the upregulation of IL-33 by intestinal
epithelium may be important factors in promoting the devel-
opment of food allergy. Environmental factors derived from
the diet or the microbiota have direct access to intestinal
epithelial cells and may regulate epithelial gene expression
to promote allergic sensitization.
It is not clear whether CT suppresses the generation of
regulatory T cells in response to antigen feeding in addition
to promoting the development of Th2 effector cells. Gane-
shan et al. [57] reported that feeding of SEB was associated
with a decrease in TGF-b and Foxp3 expression in spleno-
cytes, but did not specifically look at the induction of regula-
tory T cells. It is likely that both a suppression of regulatory
responses and an induction of effector Th2 responses are
necessary for the generation of allergic sensitization to anti-
gens in the diet. Neutralization of CTLA-4, a surfacemolecule
that mediates the regulatory activity of regulatory T cells,
leads to enhanced sensitization when adjuvant is present,
but does not in itself break tolerance [62].
Dietary Factors
Environmental influences affecting themucosal immune sys-
tem are most likely to come from the diet, the commensal
microbiota, or interactions between the two. Data from the
US Department of Agriculture comparing dietary intake
between 1970 and 2000 show significant increases in
caloric intake as well as the contribution of different food
groups to that energy intake (http://www.ers.usda.gov/
Data/FoodConsumption). For example, energy from lipids/
fats/oils and legumes/nuts/soy increased while energy
from meat/dairy/eggs decreased. Studies utilizing the
National Health and Nutrition Examination Survey (NHANES)
database or other cohorts have reported associations
between food-specific IgE levels and vitamin D [63], folate
[64] and obesity [65]; however, it should be pointed out
that concern has been raised about the accuracy of utilizing
food-specific IgE levels reported in this general population
as a proxy measure of clinical food allergy [66]. Some of
these dietary associations with food allergy are supported
by studies that potentially explain the immune basis of this
association. Alternatively, there are dietary components
that are well known to influence mucosal immunity, butwhose role in food allergy remains unstudied. An example
of the latter is vitamin A. As outlined above, the vitamin A
metabolite retinoic acid is associated with the generation
of regulatory T cells, IgA-secreting B cells, and upregulation
of gut homing receptors on T and B cells [39,41,67]. Multiple
steps are required for the transformation of dietary vitamin A
to retinoic acid, but the last step is mediated by RALDH en-
zymes. Different isoforms of RALDH are highly expressed in
the gastrointestinal tissues, and cell sources of retinoic acid
include intestinal epithelial cells, CD103+ dendritic cells, and
stromal cells of the mesenteric lymph node [68]. Vitamin
A-depleted mice lack T cells and IgA-secreting B cells in
the intestinal mucosa, but not elsewhere in the body [69].
Although retinoic acid promotes the development of regula-
tory T cells and suppresses the development of Th17 effector
T cells in vitro, findings in vivo suggest that retinoic acid is
important for induction of both regulatory and effector
T cells in the gastrointestinal mucosa [70]. For example, in
the context of high levels of the cytokine IL-15, which is a
feature of celiac disease, retinoic acid can promote the
development of pathogenic Th1 and Th17 effector cells
rather than regulatory T cells and promote celiac-like disease
in mice [71]. Thus, although much of the in vitro evidence
suggests that vitamin A should be regulatory, it has the
potential to contribute to the pathogenesis of intestinal dis-
ease. Additional mechanistic studies are needed, utilizing
both animalmodels of food allergy aswell as human subjects
to determine how dietary vitamin A levels may specifically
influence the development of food allergy.
Vitamin D is another nutrient of significant interest in the
development of tolerance or allergic sensitization to food
antigens. Serum vitamin D levels are generated both by die-
tary intake and synthesis of vitamin D in the skin in response
to exposure to sunlight. Addition of vitamin D to immuniza-
tions given by the subcutaneous route induces protective
mucosal immunity [72]. Like retinoic acid, vitamin D can influ-
ence T- and B-cell homing, and has been shown to suppress
the development of Th17 cells in vivo [73]. Vitamin D defi-
ciency also results in a depletion of a subset of intraepithelial
CD8aa-expressing T lymphocytes from the intestinal mu-
cosa [74,75]. CD8aa serves as a T-cell receptor repressor
and has been hypothesized to give these intraepithelial lym-
phocytes a regulatory function in vivo. As with vitamin A,
there is a lack of mechanistic studies in mouse models of
food allergy to test the role of vitamin D in disease. However,
there are some data from human subjects that hint at a po-
tential protective role of vitamin D in food allergy. Incidence
of food allergy varies with latitude in Australia [76] and, in the
US, rates of epinephrine auto-injector prescriptions (as a
proxy measurement of food allergy) and emergency room
visits for acute allergic reactions vary according to latitude,
with highest rates in the northeast [77]. This has been
hypothesized to be due to associated variations in vitamin
D levels resulting from differences in sun exposure. The as-
sociation of serum vitamin D levels with allergic sensitization
to common allergens was analyzed using data available in
the NHANES database. It was found that low vitamin D was
associated with elevated sensitization to peanut and shrimp,
but not milk or egg [63]. This was observed for children, but
not adults. It is not clear why this nutrient would have anti-
gen-selective effects on allergic sensitization, but this may
relate to either age or the route of antigen exposure.
Aryl hydrocarbon receptor (AHR) ligands are derived from
environmental and dietary sources and have a significant
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mucosa. Mice lacking AHR have a profound loss of intestinal
intraepithelial gd T lymphocytes [78], which are primarily
innate-type cells with invariant T-cell receptor usage. In
addition, CD8aa intraepithelial lymphocytes and lymphoid
tissue inducer cells are also lost from the intestine of mice
lacking the AHR [78,79]. This loss was associated with an
increased microbial burden in the small intestine and
increased susceptibility to experimental colitis. The intesti-
nal source of immunomodulatory ligands for the AHR is pri-
marily from food. There are also data showing that AHR
ligands modulate adaptive immune responses in the intes-
tine. Depending on the ligand used, AHR ligands could either
enhance regulatory T cells and suppress autoimmunity, or
enhance IL-17 and exacerbate autoimmunity [80]. Immuno-
modulatory effects of exogenous AHR ligands have been
shown in an experimental model of peanut allergy [81], but
it has not yet been shown whether diet-derived AHR ligands
may be protective against the development of food allergy.
Cruciferous vegetables (broccoli, cabbage, and brussels
sprouts) are rich sources of AHR ligands and may provide
ameans for modulating the immune function of the intestine.
Obesity is associated with elevated levels of IgE, including
IgE specific for common food allergens [65]. Obesity is
considered to be a systemic inflammatory state, and the
presence of innate lymphoid cells producing Th2 cytokines
within adipose tissue suggests a potential mechanistic link
between obesity and allergic disease [82]. However, a high-
fat diet is also associated with significant changes in the
local immune milieu, such as increased inflammatory
markers in the intestinal mucosa, increased epithelial perme-
ability and elevated levels of lipopolysaccharide in the
serum, and changes in the intestinal microbiome [83,84].
Interestingly, it was recently reported that both changes in
the microbiome and obesity induced by a high-fat diet
were downstream of changes in the mucosal immune sys-
tem, in particular lymphotoxin-dependent elevation of the
cytokines IL-22 and IL-23 [85]. IL-22 is a cytokine produced
by innate lymphoid cells that has both protective and pro-
inflammatory functions and IL-23 is a cytokine produced
by antigen-presenting cells that contributes to the develop-
ment of Th17 cells. The immune changes observed in these
studies were not of a Th2 phenotype that would contribute
to allergic sensitization in food allergy, but demonstrate
that the innate lymphoid milieu of the intestine can be signif-
icantly altered by the fat composition of the diet. The role of a
high-fat diet in food sensitization needs to be addressed
experimentally.
Microbiota
A second major environmental factor likely to influence
susceptibility to food allergy is the microbiota, through mod-
ulation of the mucosal immune system. All surfaces of the
human body are populated to various degrees with complex
communities of microorganisms, with the greatest density of
colonization (>1012 organisms/cm3) found within the lower
gastrointestinal tract. Studies of the last 15 years using
gnotobiotic mice (germ-free or reconstituted with defined
microbiota) have identified a critical role for the gut micro-
biota in shaping the intestinal mucosa with regard to immune
and barrier function, and influencing systemic immunity and
metabolism [86]. It is now well established that the gastro-
intestinal inflammation associated with a number of
experimental models of inflammatory bowel disease isdependent on the gut microbiota. Furthermore, reconstitu-
tion of germ-free mice with defined microbiota has identified
microbial species that promote or protect against gastroin-
testinal inflammation [87]. Particular species, including
Bacteroides fragilis and Clostridium species, promote the
development of regulatory T cells in the gastrointestinal tract
[88–90], whereas other commensal species, such as seg-
mented filamentous bacteria, promote the development of
Th17 cells [91]. Therefore, the relative abundance of various
constituents of the commensal flora may determine the im-
mune balance of the gastrointestinal tract. In the context of
allergic disease, recent work has shown that signals from
the commensal microbiota suppress IgE production and
basophil development [92], although it has been shown
that colonization with particular species, including Clos-
tridium, can suppress allergic sensitization [90]. Noval Rivas
et al. [93] recently demonstrated that a specific strain of mice
susceptible to experimental food allergy, which experienced
allergic reactions following gastric challenge with a model
food allergen, had a signature microbiota that differed from
wild-type, allergen-sensitized but non-reactive mice. Trans-
fer of this microbiota to germ-free wild-type mice promoted
allergen-specific IgE sensitization and allergic reactions
following gastric challenge in recipient mice, implicating
the microbiota in the development of food allergy. Germ-
free mice have under-developed mucosal immune systems,
so it can be difficult to interpret studies utilizing germ-free
mice in studies of diseases affecting the mucosal immune
system. However, germ-free mice and mice treated with
broad-spectrum antibiotics have increased susceptibility to
sensitization to food allergens [94,95], highlighting the gen-
eral inhibitory activity of the microbiota on the generation
of an IgE response to foods. The power of the gnotobiotic
approach comes from the ability to reconstitute germ-free
mice with defined microbiota, particularly if combined with
knowledge about the constituents of the human microbiome
associated with a particular disease. Recent studies have
shown that mice can be reconstituted with human micro-
biota, and that microbiota can then be reproducibly
controlled by altering the diet [96,97]. This is a very powerful
system for dissecting the intersection of diet, microbiota,
and human disease. It has been reported that colonization
of germ-free mice with microbiota from healthy human
infants is protective against allergic sensitization to milk
allergens [98].
What is known about the intestinal microbiome in food
allergy? Using culture-based methods, dysbiosis has been
described in a few studies comparing allergic children to
healthy controls. Bifidobacterium species have been found
to be either decreased or unchanged in allergic populations
[99,100]. Only one study to date has used 16S-based
sequencing to compare the microbiota of a group of 20
infants with atopic eczema (many with IgE sensitization to
foods) to a control group without atopic manifestations,
with a finding of reduced diversity in the microbiome of
infants with atopic eczema [101]. In addition to reductions
in diversity, there were also significant reductions in abun-
dance of the phylum Proteabacteria, but no differences in
Bifidobacterium were observed. These studies point to a
possible dysbiosis in food allergy. Larger prospective
studies are needed to identify changes in the microbiome
that precede the development of food allergy as defined by
rigorous clinical criteria, and controlling for dietary interven-
tion. If a signature of dysbiosis can be associated with food
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Figure 2. Impact of environmental factors on
allergic sensitization.
Green arrows and text indicate factors either
known or suggested to promote allergic
sensitization; red arrows and text indicate
factors suppressive to allergic sensitization
(known or suggested). Experimental adjuvant
can induce allergic sensitization through IL-33
release from epithelial cells, driving Th2
responses via OX40L on dendritic cells. In
skin, damage and decreased barrier function
can function as physiological adjuvants
driving this process, through the cytokine
TSLP acting on dendritic cells, and through
activating intraepithelial lymphocytes (IELs)
to promote a Th2 response. Dietary factors
including vitamin D, vitamin A, aryl hydrocar-
bon receptor (AHR) ligands, and folate are
thought to promote regulatory responses
or suppress inflammatory responses, while a
high-fat diet (HFD) promotes inflammatory
responses. The gut microbiota or its constitu-
ents can suppress aspects of the allergic im-
mune response, directly as shown on the left
or through the induction of regulatory T cells
as shown on the right. Effector mechanisms
of food allergy involve IgE antibodies and
cells such as basophils andmast cells. Micro-
biota can suppress basophils, or through reg-
ulatory T cells (iTregs) suppress Th2 cells that
are central to generating IgE and allergic
effector cells. Factors that promote genera-
tion of Th2 cells (adjuvants) promote food
allergy.
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reconstituted with humanmicrobiota would be warranted. In
addition to bacterial constituents of the microbiome, the
human virome may also play a significant role in shaping
the mucosal immune system [102].
Exposure to Food Allergens by Non-Oral Routes
The majority of peanut-allergic children experience their first
allergic reaction to peanut on their first known ingestion of
peanut [103]. This suggests that sensitization resulting in
IgE production must have occurred by exposure through a
non-oral route. Two leading theories for the basis of this
sensitization are in utero sensitization, or by household
exposure through non-oral routes.
In utero sensitization to allergens is thought to occur
by trans-placental transfer of antigen, and exposure of an
immature, Th2-biased (and potentially genetically predis-
posed) immune system to the allergen resulting in genera-
tion of allergic sensitization. Measurement of discordant
allergen-specific IgE in cord blood, newborn blood, and
maternal blood supports the hypothesis that IgE sensitiza-
tion may occur in utero [104]. The frequency of positive
allergen-specific IgE in cord blood mirrors the relative fre-
quency of sensitization in children (milk > egg > peanut).
The clinical data on the impact of allergen in the maternal
diet has been mixed, with some reports showing no effect
[105] and others showing that maternal ingestion of peanut
during pregnancy was a risk factor for the development of
peanut sensitization [106]. Studies utilizing animal models
to assess the impact of maternal allergen exposure during
pregnancy and/or lactation have generally found thatexposure inhibits the development of allergic sensitization
in offspring [107–109]. The mechanism of in utero tolerance
induction has not been addressed, but maternal exposure
during lactation induces oral tolerance in offspring through
a TGF-beta-dependent mechanism [108]. However, there is
no evidence from human studies supporting a protective
role of maternal allergen ingestion in food allergy.
Household non-oral exposure to peanut allergen was re-
ported to be a risk factor for peanut allergy in children, inde-
pendent of maternal ingestion during pregnancy and
lactation [110]. One relevant route of exposure was hypothe-
sized to be the skin. Peripheral blood mononuclear cells
(PBMCs) from peanut allergic donors were fractionated
into skin homing (expressing the integrin cutaneous lympho-
cyte antigen, CLA) or gut homing (expressing the integrin b7)
fractions followed by re-stimulation with peanut extract in
the presence of autologous dendritic cells [111]. Cells prolif-
erated in the CLA+ fraction, but not the b7+ fraction, leading
the authors to suggest that, based on this homing receptor
usage, sensitization likely occurred via the skin. Peanut-
specific CD4+ T cells identified by tetramer staining from
peanut-allergic subjects were classified as having frequent
expression of the skin-homing chemokine receptor CCR4
(although infrequent expression of CLA) and infrequent
expression of b7, one component of the a4b7 gut-homing in-
tegrin [112]. Further evidence fitting the hypothesis that
sensitization to peanut may occur through the skin comes
from data showing that mutations in the filaggrin gene that
are associated with decreased skin barrier function are a
risk factor for peanut allergy [113]. Data from animal models
show that allergic sensitization can be readily induced by
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Figure 3. Mechanisms of systemic and local
manifestations of food allergy.
Mast cells are central to both local and sys-
temic manifestations of food allergy. Antigen
disseminated systemically can trigger distal
reactions (urticaria, bronchospasm) through
mechanisms dependent on histamine and
platelet activating factor (PAF). Gastrointes-
tinal manifestations of food allergy in mice
are dependent on repeated exposure to the
food allergen that drives an allergic inflamma-
tion (dependent on Th2-derived cytokines,
including IL-4, IL-13, and IL-9) and masto-
cytosis that is necessary for the local symp-
toms. PAF and serotonin mediate the local
acute gastrointestinal response (diarrhea) to
allergen exposure.
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additional factors beyond exposure are necessary to induce
sensitization, including adjuvant [114], or damaging the skin
by repeatedly applying and removing tape to induce upregu-
lation of cytokines, such as TSLP and IL-21 [115,116], or in-
duction of damage signals that activate intraepithelial
lymphocytes to participate in allergic sensitization [117].
Similar to what is observed with the oral route, additional
signals are needed beyond allergen exposure to result in
allergic sensitization. The concept of damage or barrier
defects contributing to allergic sensitization via the skin is
supported by clinical observations that atopic dermatitis is
a significant risk factor for the development of food allergy
[105]. These data indicate that the skin may be a highly rele-
vant site of sensitization to food allergens. Understanding
the environmental or intrinsic co-factors that provide adju-
vant activity to food allergens upon exposure by any route
is critical to our understanding of why food allergy is a
steadily increasing clinical problem. As in the gut, the skin
microbiome has also been shown to shape skin immunity
[118] and may contribute to sensitization through cutaneous
routes. Figure 2 illustrates environmental factors that may
contribute to allergic sensitization to food allergens.
The practice of excluding allergens, such as peanut, from
the diet in infancy has been proposed as a contributing factor
in the rising incidence of peanut allergy by allowing cuta-
neous exposure to occur in the absence of tolerizing signals
from the ingestion of peanut. The Learning Early About
Peanut Allergy (LEAP) study is an ongoing interventional
study to test whether early introduction of peanut into the
diet can prevent the development of clinical peanut allergy.
Infants with egg allergy, atopic dermatitis, or both were re-
cruited into the study, and recently published baseline pa-
rameters confirmed the strong association of eczema with
peanut allergy [119]. The results from this trial will determine
whether tolerance to peanut can be induced in infants at highrisk for peanut allergy by early intro-
duction of the allergen into the diet.
There is little direct information on
the immune communication between
gut and skin in food allergy, but clearly
such communication occurs. The skin
is the most common site of manifesta-
tions of food allergy in response to oral
food challenge [120]. Evidence out-
lined above suggests that the skin isalso a likely site of initial sensitization to foods. It is not clear
whether IgE sensitization to food antigens through the skin
requires any homing of T or B cells to the gastrointestinal
tract, but there is evidence that topical immunization leads
to amucosal antibody response that is dependent on vitamin
A in the diet [121]. Clearly the potential exists for effector T
and B cells to home to the gut after antigen exposure via
the skin. Despite the fact that ingested food is the trigger
of food allergic reactions, the fact that both priming andman-
ifestations of food allergy can occur exclusively via the skin
raises the interesting question of whether food allergy should
continue to be considered a gastrointestinal disease.
Pathophysiology of Anaphylactic Reactions to Foods
Once sensitization has occurred and antigen-specific
IgE has been generated, oral re-exposure to that allergen
can lead to local or systemic manifestations of food
allergy. In human disease, the most common manifestations
of reactions are cutaneous (urticaria), followed by gastro-
intestinal and respiratory reactions [120]. Interestingly,
gastrointestinal symptoms occur in less than 50% of reac-
tions despite exposure being via the oral route. Studies
from mice indicate that food allergens must be absorbed
systemically in order to induce symptoms of anaphylaxis
[122,123] and that factors that interfere with passage across
the intestinal epithelium (such as heat aggregation of the an-
tigens) prevent anaphylactic symptoms [124,125]. The ability
to induce anaphylaxis by the oral route inmice is highly strain
and allergen dependent, but resistant strains of mice will un-
dergo anaphylaxis when systemically challenged [126,127].
The basis of this susceptibility to oral allergen challenge in
mice is not currently understood. Systemic anaphylaxis in
mice is mediated predominantly by IgE with some contribu-
tion from IgG and is dependent on mast cells, except in the
case of intravenous allergen challenge when macrophages
can also contribute to symptoms [128,129]. Histamine and
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R397platelet activating factor (PAF) are both required for systemic
manifestations of anaphylaxis in mice [127,130]. Antihista-
mines are commonly used in the treatment of acute reactions
to foods, and clinical studies have found PAF to be elevated
in the serumof subjects undergoing anaphylaxis, particularly
those with more severe symptoms [131]. PAF acetylhydro-
lase, the enzyme that breaks down PAF, is also decreased
in subjects with severe anaphylaxis [132]. PAF is elevated
in other disorders such as necrotizing enterocolitis [133],
but it remains to be determined whether PAF is a biomarker
of severe anaphylaxis in humans or whether it plays a role in
the pathogenesis.
Gastrointestinal manifestations of allergy in mice are
observed secondarily to a T-cell-driven allergic inflammation
that is induced by repeated allergen exposure [134,135]. It is
not clear why mice require repeated allergen challenge to
induce gastrointestinal symptoms, but this may relate to
the very low baseline level of resident mast cells in the
normal small intestinal lamina propria of mice. During this
repeated allergen exposure, the release of chemokines,
including CCL20, induces the accumulation of antigen-
specific Th2 cells in the intestinal mucosa [135,136]. During
repeated allergen exposure, the epithelial cytokine TSLP
is also critical for generating this local inflammation that is
necessary for symptom onset [137]. T-cell cytokines,
including IL-4, IL-13, and IL-9, are critical for generating
this allergic inflammation in the gut [138,139], likely upstream
of the expansion of mucosal mast cells. As with systemic
manifestations of anaphylaxis, allergen-induced diarrhea
is dependent on mast cells and the severity correlates
with intestinal mast cell numbers [134,140]. Mast cells
contribute to the allergic response not only through acute
release of mediators, but also as a major local source of
IL-13 [141]. Symptoms are not mediated by histamine but
instead by serotonin together with PAF [134]. It is not yet
clear whether different manifestations of food allergy in
human disease are mediated by different immune mecha-
nisms, or how antigen absorbed through the intestinal
mucosa may pass through the gut to trigger systemic symp-
toms without inducing local gastrointestinal symptoms. A
schematic illustrating our current understanding of the
mechanisms underlying manifestations of food allergy is
shown in Figure 3.Conclusions
We do not yet understand why the default immune
response to a dietary antigen deviates from a suppres-
sive responsemediated by regulatory T cells to a Th2-biased
response that promotes IgE class switching and allergic
responses upon re-exposure. The rapidly increasing inci-
dence of disease in westernized countries suggests a role
for environmental factors. Emerging evidence points to
dietary factors and the microbiome as important modifiers
of the mucosal immune environment, but further research
needs to be carried out to investigate the role of these and
other environmental factors in the development of inappro-
priate allergic sensitization to foods. Identification of modifi-
able risk factors would have a significant beneficial impact
on this perplexing disease.
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